Pharmacological treatment of acute severe hypertensives in Obstetrics: literature review

Jesser M. Herrera-Salgado, Medical Research Department, Coordination of Medical Education and Research, Instituto de Seguridad y Servicios Sociales para los Trabajadores del Estado (ISSSTE), Mexico City, Mexico
Sergio G. Monasterios-López, Respiratory Intensive Care Unit, Hospital de Alta Especialidad La Paz, La Paz, Bolivia
Waldemar A. Solis-Loria, Intensive Care Unit, Hospital Materno Perinatal Mónica Pretelini Sáenz, Toluca, State of Mexico, Mexico
Ana K. Lepe-Lemus, Intensive Care Unit, Hospital Materno Perinatal Mónica Pretelini Sáenz, Toluca, State of Mexico, Mexico
Luis E. Reyes-Mendoza, Obstetric Intensive Care, Hospital General de México Dr. Eduardo Liceaga, Mexico City, Mexico
Jesús C. Briones-Garduño, Research Coordination, HMPMPS, Toluca de Lerdo, Estado de México. Mexico
Sindy A. Gutiérrez-Chavarría, Internal Medicine, Hematology, Bone Marrow Cell Transplant Service, ISSSTE, Mexico City, Mexico

In obstetrics, hypertensive emergency is a critical state that merits the intervention of a multidisciplinary team that resolves the crisis, evaluates the well-being of the fetus, and performs adequate monitoring of the mother’s organic function. This serious condition puts the binomial at vital risk, mortality and morbidity of both can be reduced if the appropriate use of antihypertensive drugs is used. This document reviews the pharmacological management of severe arterial hypertension at initial clinical presentation, generally in the emergency department and in intensive care.